4Zoubouli CC.Retinoids which dermatological indications will benefit in the near future?[J].Skin Pharmacol Appl Skin Pharmacol,2001,14(5):303～15.
5Green L,Sadoff W.A Clinical evaluation of tazarotene 0.1% gel,with and without a high or mid high potency corticosteroid,in patients with stable plaquepsoriasis[J].J Cutan Med Surg,2002,6(2):95～102.
5Guenther L.Tazarotene combination treatments in psoriasis.J Am Acad Dermatol,2000,43:S36-S42.
6Esgleyes-Ribot T,Chandraratna RA,Lew-Kaya DA,et al.Response of psoriasis to a new topical retinoid,AGN 190168.J Am Acad Dermatol,1994,30:581-590.
7Ortonne JP. Retinoic acid and pigment cells: a review of in-vitro and in-vivo studies[J]. Br J Dermatol, 1992, 127(41): 43-47.
8Yaar M, Gilchrest BA. Human melanocyte growth and differentiation: a decade of new data[J]. J Invest Dermatol, 1991, 97(4): 611-617.
9Watabe H, Soma Y, Ito M, et al. All-trans retinoic acid induces differentiation and apoptosis of murine melanocyte precursors with induction of the microphthalmia-associated transcription factor [J]. J Invest Dermatol, 2002, 118(1): 35-42.
10Situ R, Inman DR, Fligiel SE, et al. Effects of all-transretinoic acid on melanocyte adhesion and motility [J]. Dermatology, 1993, 186 (1):38-44.
